Viral infection as an NAD+ battlefield Charles Brenner Published on 03 January 2022 Topics: NAD NAM Nicotinamide NR Nicotinamide riboside Read more about Viral infection as an NAD+ battlefield
Understanding the immune response in COVID-19 – new opportunities and new insights Professor Guy Richards - Charlotte Maxeke Academic Hospital, Johannesburg Published on July 2021 Topics: COVID-19 NAD Nicotinamide Nicotinamide riboside Nicotinic Acid Read more about Understanding the immune response in COVID-19 – new opportunities and new insights